MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with D

Danicopan

Danicopan 50mg tablets

No stability information

Stability notes for Danicopan 50mg tablets

There are no stability notes for this medicine.

Supplier

Voydeya 50mg tablets (Alexion Pharma UK Ltd)

Danicopan 50mg tablets and Danicopan 100mg tablets

No stability information

Stability notes for Danicopan 50mg tablets and Danicopan 100mg tablets

There are no stability notes for this medicine.

Supplier

Voydeya 50mg tablets and Voydeya 100mg tablets (Alexion Pharma UK Ltd)

Danicopan 100mg tablets

No stability information

Stability notes for Danicopan 100mg tablets

There are no stability notes for this medicine.

Supplier

Voydeya 100mg tablets (Alexion Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.